Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1999-10-26
pubmed:abstractText
We have used stage-specific assays for ATP-dependent priming and for Ca(2+)-activated triggering in the absence of ATP to examine the effects of myosin light chain kinase (MLCK) inhibitors, ML-9 and ML-7, and calmodulin antagonists, W-7 and trifluoperazine (TFP), on regulated exocytosis in beta-escin-permeabilized bovine adrenal chromaffin cells. Ca2+ (0.1-30 microM) induced a significantly greater secretion of catecholamines in the presence of MgATP (2 mM) than in the absence of MgATP. ML-9 (30 and 100 microM), ML-7 (30 and 100 microM), W-7 (30 and 100 microM) and TFP (10 and 30 microM) inhibited the Ca(2+)-induced catecholamine secretion in the presence of MgATP, but did not affect the catecholamine response to Ca2+ in the absence of MgATP. In intact cells all these compounds inhibited catecholamine secretion in responses to acetylcholine (100 microM) and high K+ (40 mM). The results obtained in permeabilized cells suggest that the calmodulin-MLCK system plays an essential role in the ATP-requiring priming stage but not in the Ca2(+)-triggered fusion step in the exocytotic process in bovine adrenal chromaffin cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholine, http://linkedlifedata.com/resource/pubmed/chemical/Adenosine Triphosphate, http://linkedlifedata.com/resource/pubmed/chemical/Azepines, http://linkedlifedata.com/resource/pubmed/chemical/Calcium, http://linkedlifedata.com/resource/pubmed/chemical/Calmodulin, http://linkedlifedata.com/resource/pubmed/chemical/Catecholamines, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Escin, http://linkedlifedata.com/resource/pubmed/chemical/ML 7, http://linkedlifedata.com/resource/pubmed/chemical/ML 9, http://linkedlifedata.com/resource/pubmed/chemical/Myosin-Light-Chain Kinase, http://linkedlifedata.com/resource/pubmed/chemical/Naphthalenes, http://linkedlifedata.com/resource/pubmed/chemical/Potassium, http://linkedlifedata.com/resource/pubmed/chemical/Trifluoperazine
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0144-1795
pubmed:author
pubmed:issnType
Print
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
115-21
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:10466945-Acetylcholine, pubmed-meshheading:10466945-Adenosine Triphosphate, pubmed-meshheading:10466945-Adrenal Glands, pubmed-meshheading:10466945-Animals, pubmed-meshheading:10466945-Azepines, pubmed-meshheading:10466945-Calcium, pubmed-meshheading:10466945-Calmodulin, pubmed-meshheading:10466945-Catecholamines, pubmed-meshheading:10466945-Cattle, pubmed-meshheading:10466945-Cell Membrane Permeability, pubmed-meshheading:10466945-Cells, Cultured, pubmed-meshheading:10466945-Chromaffin Cells, pubmed-meshheading:10466945-Dose-Response Relationship, Drug, pubmed-meshheading:10466945-Enzyme Inhibitors, pubmed-meshheading:10466945-Escin, pubmed-meshheading:10466945-Exocytosis, pubmed-meshheading:10466945-Myosin-Light-Chain Kinase, pubmed-meshheading:10466945-Naphthalenes, pubmed-meshheading:10466945-Potassium, pubmed-meshheading:10466945-Trifluoperazine
pubmed:year
1999
pubmed:articleTitle
Myosin light chain kinase inhibitors and calmodulin antagonist inhibit Ca(2+)- and ATP-dependent catecholamine secretion from bovine adrenal chromaffin cells.
pubmed:affiliation
Department of Dental Pharmacology, The Nippon Dental University School of Dentistry at Niigata, Hamauracho, Japan.
pubmed:publicationType
Journal Article